You have 9 free searches left this month | for more free features.

Aromatase Inhibitors

Showing 1 - 25 of 4,600

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Musculoskeletal Health in Breast Cancer During Aromatase

Recruiting
  • Musculoskeletal Health
  • No intervention
  • Shanghai, Shanghai, China
    School of Nursing, Fudan University
Jun 16, 2023

Estrogen Receptor-Positive Breast Carcinoma Trial in Rochester (dietary supplement, drug, other)

Not yet recruiting
  • Estrogen Receptor-Positive Breast Carcinoma
  • Mushroom
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 31, 2023

Sleep and Pain Among Breast Cancer Survivors on Aromatase

Not yet recruiting
  • Breast Cancer
  • +6 more
  • No intervention
  • (no location specified)
Dec 3, 2022

Breast Cancer Female, Hormone-receptor-positive Breast Cancer Trial in Lisboa (Brief Physical Activity Counselling, Structured

Recruiting
  • Breast Cancer Female
  • Hormone-receptor-positive Breast Cancer
  • Brief Physical Activity Counselling
  • Structured Exercise Program
  • Lisboa, Portugal
    Universidade Lusófona, Campo Grande 376
May 5, 2023

Genitourinary Syndrome of Menopause Trial in Leuven (intravaginal laser)

Recruiting
  • Genitourinary Syndrome of Menopause
  • intravaginal laser
  • Leuven, Flemish Brabant, Belgium
    UZ Leuven
Jan 26, 2023

Breast Cancer, Osteopenia Trial in Valencia (bone densitometry)

Recruiting
  • Breast Cancer
  • Osteopenia
  • bone densitometry
  • Valencia, Spain
    Hospital Clínico Universitario de Valencia
Mar 9, 2023

Ribociclib in Combination With Non-steroidal Aromatase

Completed
  • Breast Cancer
  • Sao Paulo, SP, Brazil
    Novartis Investigative Site
Nov 7, 2022

Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

Recruiting
  • Luminal B/HER2-negative Breast Cancer
  • Dalpiciclib combined with aromatase inhibitors
  • anthracycline-cyclophosphamide followed by taxane
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022

Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

Terminated
  • Breast Cancer
  • Breast Cancer Metastatic
  • Niraparib 100 MG
  • Aromatase Inhibitors
  • A Coruña, Spain
  • +9 more
Jan 17, 2023

Breast Cancer Trial in Pittsburgh (Value Affirmation, Reflective Journaling)

Recruiting
  • Breast Cancer
  • Value Affirmation
  • Reflective Journaling
  • Pittsburgh, Pennsylvania
    Carnegie Mellon University
Jul 25, 2022

Breast Cancer, Genitourinary Syndrome of Menopause Trial in Barcelona (CO2 LASER, CO2 SHAM LASER)

Active, not recruiting
  • Breast Cancer
  • Genitourinary Syndrome of Menopause
  • CO2 LASER
  • CO2 SHAM LASER
  • Barcelona, Spain
    Eduard Mension Coll
Jun 2, 2022

Breast Cancer Trial in Kyoto (Denosumab Injection)

Recruiting
  • Breast Cancer
  • Denosumab Injection
  • Kyoto, Japan
    Hisako Ono
Mar 30, 2022

Breast Cancer, Aromatase Inhibitors Trial in Montpellier, Nîmes (Whole-body cryotherapy, Placebo cryotherapy)

Not yet recruiting
  • Breast Cancer
  • Aromatase Inhibitors
  • Whole-body cryotherapy
  • Placebo cryotherapy
  • Montpellier, France
  • +1 more
Jul 28, 2022

Hypogonadism, Hypogonadotropic, Obesity Trial in Houston (anastrozole (1 mg/day), Placebo)

Recruiting
  • Hypogonadism, Hypogonadotropic
  • Obesity
  • anastrozole (1 mg/day)
  • Placebo
  • Houston, Texas
    Michael E. DeBakey VAMC
Jan 19, 2022

Breast Cancer Trial in Xining (Acupuncture group)

Recruiting
  • Breast Cancer
  • Acupuncture group
  • Xining, Qinghai, China
    Affiliated Hospital of Qinghai University
Nov 7, 2021

ER+ Breast Cancer, Breast Cancer, Aromatase Inhibitors Trial in Boston (White Wine, Grape Juice)

Not yet recruiting
  • ER+ Breast Cancer
  • +2 more
  • White Wine
  • Grape Juice
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 1, 2022

Breast Cancer Trial in Los Angeles (Carbohydrate restricted dietary intervention, standard of care aromatase inhibitors)

Recruiting
  • Breast Cancer
  • Carbohydrate restricted dietary intervention
  • standard of care aromatase inhibitors
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 30, 2022

Bone Complications in People With Post-menopausal Breast Cancer

Recruiting
  • Breast Cancer
  • Physical Evaluation
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 20, 2022

Breast Cancer, Stiffness of Hand, Not Elsewhere Classified Trial in Xining (Acupuncture)

Recruiting
  • Breast Cancer
  • Stiffness of Hand, Not Elsewhere Classified
  • Acupuncture
  • Xining, Qinghai, China
    Affiliated Hospital of Qinghai University, Affiliated Cancer Hos
Nov 9, 2021

Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)

Recruiting
  • Breast Cancer
  • Prato, Please Select:, Italy
    Hospital of Prato
Jul 27, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +15 more
  • Dietary Intervention
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 23, 2022

Vulvar Atrophy, Breast Cancer, Genitourinary Syndrome of Menopause Trial in Barcelona (Prasterone (DHEA), Micronized)

Completed
  • Vulvar Atrophy
  • +2 more
  • Prasterone (DHEA), Micronized
  • Barcelona, Spain
    Hospital Clínic de Barcelona
Feb 20, 2022

Breast Cancer Trial in Baltimore (Anastrozole, Letrozole)

Recruiting
  • Breast Cancer
  • Baltimore, Maryland
    University of Maryland Greenebaum Cancer Center
Apr 29, 2022

Musculoskeletal Pain, Breast Cancer Trial in France (Auriculotherapy for analgesic use, Placebo auriculotherapy)

Recruiting
  • Musculoskeletal Pain
  • Breast Cancer
  • Auriculotherapy for analgesic use
  • Placebo auriculotherapy
  • Caen, France
  • +6 more
Nov 9, 2021

Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

Recruiting
  • Breast Neoplasm
  • +4 more
  • PIK3CA inhibitor
  • +12 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023